NDC 0023-6147

RAPAFLO

Silodosin

RAPAFLO is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Silodosin.

Product ID0023-6147_6cba0207-6e74-431e-9298-710b5fc592d4
NDC0023-6147
Product TypeHuman Prescription Drug
Proprietary NameRAPAFLO
Generic NameSilodosin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2009-03-23
Marketing CategoryNDA / NDA
Application NumberNDA022206
Labeler NameAllergan, Inc.
Substance NameSILODOSIN
Active Ingredient Strength4 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0023-6147-30

30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0023-6147-30)
Marketing Start Date2009-03-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0023-6147-30 [00023614730]

RAPAFLO CAPSULE
Marketing CategoryNDA
Application NumberNDA022206
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-03-23

Drug Details

Active Ingredients

IngredientStrength
SILODOSIN4 mg/1

OpenFDA Data

SPL SET ID:da0314f6-b1d6-44ee-8b1e-f763dbb8613f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 809481
  • 826614
  • 826612
  • 809477
    • UPC Code
  • 0300236147303

    • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]
    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "RAPAFLO" or generic name "Silodosin"

    NDCBrand NameGeneric Name
    0023-6142RAPAFLOsilodosin
    0023-6147RAPAFLOsilodosin
    52544-151RAPAFLOsilodosin
    52544-152RAPAFLOsilodosin
    0781-2623SilodosinSilodosin
    0781-2624SilodosinSilodosin
    27241-144SilodosinSilodosin
    27241-145SilodosinSilodosin
    31722-635SilodosinSilodosin
    31722-636SilodosinSilodosin
    33342-384SilodosinSilodosin
    33342-385SilodosinSilodosin
    42291-777SilodosinSilodosin
    42291-778SilodosinSilodosin
    46708-405SilodosinSilodosin
    46708-406SilodosinSilodosin
    59651-095SILODOSINSILODOSIN
    59651-096SILODOSINSILODOSIN

    Trademark Results [RAPAFLO]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RAPAFLO
    RAPAFLO
    78634385 3644962 Live/Registered
    Watson Pharmaceuticals, Inc.
    2005-05-20
    RAPAFLO
    RAPAFLO
    77605175 3681361 Live/Registered
    Watson Pharmaceuticals, Inc.
    2008-10-31
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.